NICOLE ZALEWSKI: Open Payments
NPI 1700811502 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 13 payments from 8 companies in 2025. Trend: 2023 $857 · 2024 $974 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $174 |
| SI-BONE, INC. | 1 | $152 |
| UCB, Inc. | 2 | $103 |
| Lilly USA, LLC | 3 | $80 |
| ABBVIE INC. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Eisai Inc. | 1 | $29 |
| Integra LifeSciences Corporation | 1 | $17 |
Products named: AMVUTTRA, Rystiggo, KISUNLA, AUSTEDO XR, QULIPTA, Leqembi, UBRELVY, CODMAN CERTAS.
Industry payments across WA — which companies pay providers there.
